Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin for Enteral Nutrition Intolerance in PICU
NCT05828758Phase 3Unknown
- Sponsor
- Sohag University
- Start
- Apr 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of amoxicillin in enteral feeding intolerance (EFI) (2 arms), sponsored by Sohag University. Primary endpoint: Feeding tolerance on day 7. Status: unknown.
02
Drugs
amoxicillin
03
Conditions
enteral feeding intolerance (EFI)
Beyond the preview
Go deeper on NCT05828758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05828758.